Our purpose is to redefine the treatment of acute thrombotic conditions

Today, too many patients go untreated because existing therapies have limited effectiveness, carry safety risks, have narrow treatment windows or rely on specialized care that isn’t always available. We’re driven by the urgency to give clinicians safer, more effective treatment options in the moments that matter most—when restoring blood flow can mean the difference between recovery and lifelong disability or death.

We’re developing a potent, targeted therapy with a rationally-designed, direct-acting reversal agent—reflecting a fundamentally new way to treat thrombotic conditions.

Our work is guided by a simple belief: intervene smarter to achieve better outcomes.

vision

A future where life-saving clot intervention is more precise, safer and within reach for more patients